Analyst Ratings for BioSante Pharmaceuticals (BPAX)

BPAX Rating Summary

  |   Expand Research on BPAX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 0 / 10   Percentile Rank: 11%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/15/2011 Roth/MKM N/A Downgrade Neutral
(N/A)		 N/A
(N/A)		 2.12
(1.09)		 -48.58% Details
12/15/2011 Jefferies N/A Downgrade Hold
(N/A)		 N/A
(N/A)		 2.12
(1.09)		 -48.58% Details